Aberrant Expression of HOXA9, DEK, CBL and CSF1R in Acute Myeloid Leukemia

Previous gene function analyses have indicated that HOXA9, DEK, CBL and CSF1R are aberrantly expressed in acute myeloid leukemia (AML). We analyzed the expression of these genes in a series of 41 adult patients with AML using quantitative real-time RT-PCR, and tested the association of the expression with the following hematologic and clinical parameters: age, FAB, immunophenotype and karyotype aberrations. A high proportion of the patients showed over- or underexpression of the analyzed genes. DEK was overexpressed in 98% of the cases, whereas CBL, CSF1R and HOXA9 were either overexpressed in 20%, 17% and 78% or underexpressed in 20%, 42% and 15% of the cases, respectively. Patients whose karyotype contained t(8;21)(q22;q22), showed lower relative expression of HOXA9 at a statistically significant level <formula>(<italic>p</italic><0.05).</formula> Bone marrow samples without expression of CD34 antigen were associated with either overexpression of DEK or HOXA9. Furthermore, an association was found between the AML-M2 subtype and lower expression of CBL, CSF1R or HOXA9, and between the AML-M5 subtype and CBL or CSF1R overexpression.

[1]  H. Mannila,et al.  Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia – a cDNA array study , 2002, Leukemia.

[2]  A. Baron,et al.  Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia , 2002, Leukemia.

[3]  M. Vihinen,et al.  Overexpression of translocation-associated fusion genes of FGFR 1 , MYC , NPM 1 , and DEK , but absence of the translocations in acute myeloid leukemia . A microarray analysis , 2002 .

[4]  F. O. Fackelmayer,et al.  Subcellular Localization of the Human Proto-oncogene Protein DEK* , 2001, The Journal of Biological Chemistry.

[5]  B. Blencowe,et al.  The Acute Myeloid Leukemia-Associated Protein, Dek, Forms a Splicing-Dependent Interaction with Exon-Product Complexes , 2000, The Journal of cell biology.

[6]  L. Kömüves,et al.  Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias , 1999, Leukemia.

[7]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[8]  D. Bowtell,et al.  The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.

[9]  I. Bièche,et al.  Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. , 1999, Cancer research.

[10]  R. Humphries,et al.  Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells , 1999, Leukemia.

[11]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[12]  Keisuke Toyama,et al.  The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9 , 1996, Nature Genetics.

[13]  A. Feinberg,et al.  Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia , 1996, Nature Genetics.

[14]  G. Sauvageau,et al.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Hagemeijer,et al.  The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features , 1992 .

[16]  M. Fornerod,et al.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA , 1992, Molecular and cellular biology.

[17]  P Roth,et al.  The biology of CSF-1 and its receptor. , 1992, Current topics in microbiology and immunology.

[18]  A. Hagemeijer,et al.  The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. , 1992, Blood.

[19]  S. Klinken,et al.  v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .